de Armas FMC, González QM, Ugarte MD, Ladrón de Guevara RN, Candebat SM, Mosqueda FM

Language: Spanish
References: 11
Page: 158-162
PDF size: 344.69 Kb.

ABSTRACT

The metaplastic carcinoma of the breast is rare and the incidence that he has been reported with he oscillates around the 5%, in addition to his shadowy prognosis. Objective:Method: Appropriate description and looking up literature. Result: histological diagnosis is defined in the biopsy for paraffin, where in addition to the hematoxilina and eosina, the scoreboards inmunohistoquimicos like Receptor of estrogen, progesterone, HER2, Ki67, p63, CK 5/6, HER1 among others. Conclusions: An infrequent form comes from mammary Carcinoma than given prognosis entails his morphologic characteristics badly.

REFERENCES

1. Tavassoli FA. Pathology of the breast. Norwalk. Appleton and Lange; 1992. p. 3-10.

2. 2-Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K, et al. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Canc Res. 2005;7(6):1028-35.

3. Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, et al. May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis. Med Oncol. 2011;28(1):42-50.

4. Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, et al. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. Breast Canc Res Treat. 2011;126(2):471-8.

5. Lee H, Jung SY, Ro JY, Kwon Y, Sohn JH, Park IH, et al. Metaplastic breast cancer: clinicopathological features and its prognosis. J Clin Pathol. 2012;65(5):441-6.

6. Jung SY, Kim HY, Nam BH, Min SY, Lee SJ, Park C, et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Canc Res Treat. 2010;120(3):627-37.

7. Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Maeda I, Shin-ichi T, et al. Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma. Med Molecul Morphol. 2012;45(1):14-21.

8. Koker M, Kleer C. Expression in breast cancer: A highly sensitive and specific marker of metaplastic carcinoma. Americ Journ of Surg Patholo. 2004;28(11):1506-12.

9. Barquet SA, Villarreal SP, Cantú DF, Rangel HA, Lozano RA, López RA, et al. Metaplastic breast cancer: clinical factors. Gac Med Mex. 2012;148(4):339-48.

10. Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, et al. Metaplastic breast carcinomas are basal-like tumours. Histopatholo. 2006;49(1):10-21.

11. Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: Imaging findings and pathologic features. J Clin Imaging Sci. 2012;2(1):21.